Hong Zhang Selected Research

Radiotherapy

12/2024	Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review.
3/2024	Evaluation of the efficacy and safety of a precise thymalfasin-regulated PRaG regimen for advanced refractory solid tumours: protocol for the open-label, prospective, multicentre study (PRaG5.0 study).
2/2024	Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells.
6/2023	Measurements of target volumes and organs at risk using DW‑MRI in patients with central lung cancer accompanied with atelectasis.
5/2023	Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence.
5/2023	High expression of cytoplasmic FOXO3 protein associated with poor prognosis of rectal cancer patients: A study from Swedish clinical trial of preoperative radiotherapy to big database analysis.
5/2023	A Clinical Series in Patients with Naso-Pharyngeal Cancer and Their Outcomes with Stent Graft Treatment for Sentinel Bleeding to Prevent Frank Carotid Rupture.
2/2023	Mitochondrial-Targeted Antioxidant MitoQ-Mediated Autophagy: A Novel Strategy for Precise Radiation Protection.
1/2023	Association of MicroRNA-652 Expression with Radiation Response of Colorectal Cancer: A Study from Rectal Cancer Patients in a Swedish Trial of Preoperative Radiotherapy.
1/2023	Carbon ions trigger DNA damage response to overcome radioresistance by regulating β-catenin signaling in quiescent HeLa cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Zhang Research Topics

Disease

672	Neoplasms (Cancer) 12/2024 - 05/2002
162	Inflammation (Inflammations) 03/2024 - 06/2002
136	Infections 04/2024 - 06/2002
115	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2002
113	IGA Glomerulonephritis (IGA Nephropathy) 04/2024 - 01/2004
100	Breast Neoplasms (Breast Cancer) 01/2024 - 08/2004
64	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 04/2002
57	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 08/2005
56	Fibrosis (Cirrhosis) 11/2023 - 07/2002
54	Proteinuria 04/2024 - 12/2007
51	Carcinogenesis 02/2024 - 03/2004
50	Stroke (Strokes) 05/2024 - 07/2004
50	Ischemia 11/2023 - 07/2003
46	Wounds and Injuries (Trauma) 04/2024 - 07/2003
46	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 10/2004
45	Type 2 Diabetes Mellitus (MODY) 07/2023 - 05/2005
44	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 06/2007
43	Carcinoma (Carcinomatosis) 01/2024 - 11/2002
42	Pain (Aches) 05/2024 - 10/2003
42	Hypertension (High Blood Pressure) 04/2024 - 08/2004
40	Hypoxia (Hypoxemia) 04/2024 - 03/2003
39	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 02/2005
38	Lung Neoplasms (Lung Cancer) 12/2023 - 09/2003
37	Body Weight (Weight, Body) 03/2024 - 06/2002
34	Glioma (Gliomas) 01/2024 - 07/2006
33	Cognitive Dysfunction 01/2024 - 09/2011
31	Necrosis 12/2023 - 12/2002
31	Reperfusion Injury 05/2023 - 06/2004
30	Chronic Renal Insufficiency 06/2023 - 03/2003
29	Disease Progression 03/2024 - 01/2004
29	Sepsis (Septicemia) 02/2024 - 01/2006
28	Myocardial Infarction 05/2024 - 05/2003
27	Colonic Neoplasms (Colon Cancer) 12/2023 - 09/2003
27	Parkinson Disease (Parkinson's Disease) 08/2023 - 10/2006
27	Lung Injury 01/2023 - 07/2002
27	Brain Ischemia (Cerebral Ischemia) 05/2022 - 01/2005
26	Cardiovascular Diseases (Cardiovascular Disease) 12/2024 - 08/2010
26	Hemorrhage 03/2024 - 04/2002
26	Obesity 03/2024 - 04/2005
26	Chronic Kidney Failure (Chronic Renal Failure) 12/2023 - 06/2003
25	Insulin Resistance 02/2024 - 07/2005
25	Lymphatic Metastasis 01/2023 - 03/2003
24	COVID-19 01/2024 - 01/2020
23	Glaucoma 03/2024 - 07/2004
23	Stomach Neoplasms (Stomach Cancer) 12/2023 - 03/2003
23	Melanoma (Melanoma, Malignant) 06/2022 - 07/2002
22	Rectal Neoplasms (Rectal Cancer) 12/2024 - 11/2005
22	Infarction (Infarctions) 05/2024 - 07/2004
22	Kidney Diseases (Kidney Disease) 05/2023 - 02/2012
21	Pneumonia (Pneumonitis) 02/2024 - 12/2006
21	Heart Failure 01/2024 - 08/2004
21	Renal Insufficiency (Renal Failure) 01/2024 - 08/2008
21	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 12/2004
21	Triple Negative Breast Neoplasms 11/2023 - 01/2013
21	Diabetic Nephropathies (Diabetic Nephropathy) 11/2023 - 09/2003

Drug/Important Bio-Agent (IBA)

321	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2002
145	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2005
86	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 09/2002
78	Messenger RNA (mRNA)IBA 03/2024 - 07/2002
78	CytokinesIBA 03/2024 - 06/2003
70	MicroRNAs (MicroRNA)IBA 12/2023 - 06/2011
68	Therapeutic UsesIBA 05/2024 - 08/2002
50	DNA (Deoxyribonucleic Acid)IBA 05/2023 - 03/2003
49	Immunoglobulin A (IgA)IBA 04/2024 - 10/2007
41	LipidsIBA 12/2023 - 06/2008
39	RNA (Ribonucleic Acid)IBA 03/2024 - 09/2003
39	Long Noncoding RNAIBA 12/2023 - 04/2015
38	EnzymesIBA 04/2024 - 01/2003
38	CreatinineIBA 03/2024 - 09/2003
38	salicylhydroxamic acid (SHAM)IBA 02/2024 - 07/2003
33	CarbonIBA 12/2023 - 03/2008
32	AntioxidantsIBA 01/2024 - 12/2003
30	Peptides (Polypeptides)IBA 01/2024 - 05/2005
30	Interleukin-6 (Interleukin 6)IBA 12/2023 - 09/2002
28	CateninsIBA 12/2024 - 10/2009
28	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 06/2002
27	Antiviral Agents (Antivirals)IBA 01/2024 - 09/2009
25	LigandsIBA 04/2024 - 12/2002
25	CalciumIBA 03/2024 - 07/2003
25	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 06/2002
25	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2002
24	Small Interfering RNA (siRNA)IBA 04/2024 - 06/2009
24	LipopolysaccharidesIBA 01/2024 - 06/2002
23	Indicators and Reagents (Reagents)IBA 03/2024 - 08/2004
23	AntigensIBA 01/2024 - 12/2004
23	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2023 - 06/2003
23	Retinaldehyde (Retinal)IBA 11/2023 - 06/2004
21	Adenosine Triphosphate (ATP)IBA 12/2023 - 08/2005
21	VaccinesIBA 10/2023 - 12/2006

Therapy/Procedure

356	Therapeutics 05/2024 - 09/2002
104	Drug Therapy (Chemotherapy) 12/2024 - 11/2002
96	Radiotherapy 12/2024 - 05/2005
47	Immunotherapy 12/2024 - 12/2004
36	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2023 - 05/2008
35	Electroacupuncture 10/2023 - 11/2008
29	Aftercare (After-Treatment) 05/2024 - 01/2002
23	Transplantation 01/2024 - 07/2004
23	Neoadjuvant Therapy 12/2023 - 07/2008
22	Lasers (Laser) 01/2024 - 11/2003
21	Length of Stay 01/2023 - 11/2009